GO(2) Foundation for Lung Cancer, Washington, District of Columbia.
AstraZeneca, Cambridge, United Kingdom.
J Thorac Oncol. 2021 Jan;16(1):151-155. doi: 10.1016/j.jtho.2020.09.011. Epub 2020 Oct 1.
Lung cancer stigma negatively impacts the clinical care and outcomes of those diagnosed, resulting in enduring disparities. The objective of this study was to determine whether attitudes toward lung cancer and the stigmatization of people diagnosed have changed over a decade.
A cross-sectional survey was administered to the general public, oncologists, and people with lung cancer 10 years apart (2008 and 2018) using the same instrument and methodology. The measures of stigma agreement ratings on a five-point Likert scale were compared between 2008 and 2018 for all three sample groups.
In 2018, a total of 1001 members of the general public, 205 oncologists, and 208 people with lung cancer were enrolled. Improvements were noted over the decade, including the availability of more treatment options. Greater disease awareness was also found, with 94% of the public reporting knowledge of lung cancer (versus 82.5% in 2008, p < 0.0001). However, no change was found in the percentage of the public reporting that patients with lung cancer are at least partially to blame for their illness (60.3% in 2018). In 2018, more people with lung cancer agreed there is a stigma associated with lung cancer (72.1 versus 54.5%, p < 0.001) and that those diagnosed are viewed or treated differently by society in general (69.4% versus 50.8%, p < 0.001).
The results reflect recognition of treatment gains and increased visibility of lung cancer but also highlight that stigma remains a significant problem. Of critical importance to the care of those diagnosed was the unexpected increase in stigma reported by the patient population.
肺癌污名化对被诊断出患有肺癌的患者的临床护理和预后产生负面影响,导致长期存在差异。本研究的目的是确定对肺癌的态度以及对被诊断出患有肺癌的人的污名化是否在十年内发生了变化。
采用相同的工具和方法,在十年间(2008 年和 2018 年)对普通公众、肿瘤学家和肺癌患者进行了横断面调查。使用五点 Likert 量表对 2008 年和 2018 年所有三组样本的污名认同评价进行比较。
2018 年,共有 1001 名普通公众、205 名肿瘤学家和 208 名肺癌患者参与了调查。研究发现,在这十年中,包括更多的治疗选择在内的情况有所改善。疾病意识也有所提高,94%的公众表示了解肺癌(而 2008 年为 82.5%,p<0.0001)。然而,公众中认为肺癌患者至少对其疾病负有部分责任的比例并没有变化(2018 年为 60.3%)。2018 年,更多的肺癌患者认为肺癌存在污名化问题(72.1%比 54.5%,p<0.001),并且社会通常对被诊断出患有肺癌的人有不同的看法或对待方式(69.4%比 50.8%,p<0.001)。
结果反映了对治疗进展的认识和肺癌可见度的提高,但也突出表明污名化仍然是一个重大问题。对被诊断出患有肺癌的人的护理至关重要的是,患者群体报告的污名化问题意外增加。